Long-term outcomes of anti-vascular endothelial growth factor therapy with and without posterior scleral reinforcement on myopic maculopathy in myopic choroidal neovascularization eyes

Anti-vascular endothelial growth factor (anti-VEGF) therapy is used for myopic choroidal neovascularization (mCNV). Patchy chorioretinal atrophy (pCRA) enlargement has been reported in mCNV cases associated wi...

Source: BMC Ophthalmology - March 13, 2024 Category: Opthalmology Authors: Meng-Tian Kang, Ningli Wang, Wenjun Xu, Mayinuer Yusufu, Wu Liu, Jiaxin Tian and Yue Qi Tags: Research Source Type: research